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Background: Laser lithotripsy is an established endourological modality. Ho:YAG laser have broadened the
indications for ureteroscopic stone managements to include larger stone sizes throughout the whole upper
urinary tract. Aim of current work is to assess efficacy and safety of Ho:YAG laser lithotripsy during retrograde
ureteroscopic management of ureteral calculi in different locations.
Methods: 88 patients were treated with ureteroscopic Ho:YAG laser lithotripsy in our institute. Study endpoint was
the number of treatments until the patient was stone-free. Patients were classified according to the location of their
stones as Group I (distal ureteric stones, 51 patients) and group II (proximal ureteral stones, 37). Group I patients
have larger stones as Group II (10.70 mm vs. 8.24 mm, respectively, P = 0.020).
Results: Overall stone free rate for both groups was 95.8%. The mean number of procedures for proximal calculi
was 1.1 ± 0.1 (1–3) and for distal calculi was 1.0 ± 0.0. The initial treatment was more successful in patients with
distal ureteral calculi (100% vs. 82.40%, respectively, P = 0.008). No significant difference in the stone free rate was
noticed after the second laser procedure for stones smaller versus larger than 10 mm (100% versus 94.1%, P = 0.13).
Overall complication rate was 7.9% (Clavien II und IIIb). Overall and grade-adjusted complication rates were not
dependant on the stone location. No laser induced complications were noticed.
Conclusions: The use of the Ho:YAG laser appears to be an adequate tool to disintegrate ureteral calculi
independent of primary location. Combination of the semirigid and flexible ureteroscopes as well as the
appropriate endourologic tools could likely improve the stone clearance rates for proximal calculi regardless
of stone-size.
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Laser technologies are established standard modalities
for application on lithotripsy [1]. The introduction of the
Ho:YAG laser have broadened the indications for ure-
teroscopic stone managements (URS) to include larger
stone sizes throughout the whole upper urinary tract [2].
Furthermore, recent developments in the design of ure-
teroscopy and endoscopic instruments have enabled the
URS to replace the open surgery treatments for urinary* Correspondence: wael.khoder@med.uni-muenchen.de
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modality.
The Nephrolithiasis Guidelines of both the European
Association of Urology (EAU) and American Urological
Association (AUA) have focused on the changes in ur-
eteral stone managements. According to these guidelines,
the extracorporeal shock wave lithotripsy (SWL) and URS
remain the two primary treatment modalities for the man-
agement of symptomatic ureteral calculi [3]. This was
based on their meta-analysis. There was no difference in
stone-free rates between SWL and URS after all primary
procedures in the proximal ureter (82% versus 81%, re-
spectively). This was dependent on the stone size. For
small proximal stones (<10 mm), SWL stone free rate wasLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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for larger stones (>10 mm), URS stone free rate was su-
perior (79% versus 68%, respectively). Interestingly, URS
yields better stone-free rates for distal stones independent
of the size (94.5%5 versus 74%, respectively) [3].
We assessed the safety and efficacy of Ho:YAG laser
based endoscopic treatment of ureteral calculi whether
with a semirigid or flexible ureteroscopy on the improve-
ment of stone-free rates of proximal and distal ureteral
stones. In addition, the influence of stone size on the out-
come following this ureteroscopic laser lithotripsy was stud-
ied for proximal ureteral stones (≤10 mm vs. > 10 mm).
Methods
Data of 88 patients (25 women and 63 men) who under-
went Ho:YAG laser lithotripsy for ureteral stones over two
years from June 2011 to June 2013 at our institution were
retrospectively reviewed. To omit the experience of the
surgeon as a factor in the analysis of the results, two expe-
rienced surgeons have operated all the patients of the
current study. Ethical approval was obtained from the
department of urology, Ludwig-Maximilians-University
Ethical Committee.
These were classified into 2 groups according to pos-
ition of ureteric stones; distal ureteral stones below the
pelvic brim (37 patients, group I) and proximal ureteral
stones located above the pelvic brim (51, group II).
All patients underwent pre- and post-operative laboratory
examinations, including blood pictures, serum biochemistry
and urine analysis. Patients with preoperative urinary tract
infections received antibiotic therapy according to the
culture-specific tests until the culture became negative for
infection. Stone size was determined based on the pre-
operative plain abdominal x-ray or CT examinations.
Total linear calculus diameter equals the measured largest
linear dimension (transverse or cranio-caudal section) or
the sum of the linear measurements of individual calculi
for multiple ureteral calculi in one system.
Postoperative evaluation included plain abdominal
films taken immediately after treatment before leaving
the operating theater. Patients were followed up for a
minimum of 3 months with abdominal ultrasonography,
plain x-rays or CT scans to exclude obstructive hydrone-
phrosis and to verify the residual stone burden, if
present. The study has been approved by our department
committee.
Assessment of the procedure outcomes included stone
free and complication rates. Stone freedom was defined
as pulverization of all calculi to fine dust or fragments
not larger than 2 mm in diameter on x-ray imaging at
the end of procedure. This was considered to be too
small to extract and was liable to pass spontaneously [3].
Patients requiring re-procedures or SWL during follow-
up were considered as treatment failures. Operative timewas calculated from begin of cystoscopy till the removal
of all equipment.
Laser lithotripsy equipment
Ho:YAG laser system (Auriga XL, Starmedtec, Starnberg,
Germany) with laser fiber diameter of 365 μm was used
with the semirigid ureteroscopes. Fibers with 220 μm
diameter were used for the flexible ureteroscopes to avoid
compromising both irrigation flow and the maximal endo-
scope tip deflection.
Operative instrumentation and technique
The ureteroscopic manipulations of the upper urinary
tract are adequately described [2,4,5], here in brief;
Under general anesthesia, dorsal lithotomy position,
and after sterilization and sterile coverings, a diagnostic
22 F cystoscopy was done. Spinal anesthesia are not a
common approach in our department as both patients
and anesthists advice general anesthesia. This is followed
with identification of the ureteral orifice and its cannula-
tion with 0.038-inch hydrophilic guide wire under fluoro-
scopic guidance. A 16 F transurethral catheter is inserted
for drainages to prevent bladder distension during con-
tinuous irrigation.
Ureteroscopic procedures were done either with semi-
rigid ureteroscopes (diameter from 7 F to 9,5 F) or 7.5 F
flexible ureteroscopes implying double active tip deflec-
tion mechanism and maintaining a 3.6 F-working channel
(Storz Flex X2, Storz Tutlingen, Germany). The flexible
ureteroscope was positioned via a 12 F ureteral access
sheath (Cook Medical Bloomington, Illinois, USA) that
was placed over the guide wire. These ureteral access
sheaths allow frequent passage of the ureteroscope to the
upper urinary tract, enable optimal visualization, maintain
low intra-renal pressure and hasten calculi fragments
extraction. Ureteric manipulations were aiming to direct
laser shock impulses to the middle of stones and their
fragments under direct vision to allow fragmentation
without ureteric injuries.
Basket stone removal was considered for fragments
>2 mm in size after laser fragmentation to achieve sam-
ples for stone composition analysis. Staged therapy was
considered in case of a bad visibility limiting further ac-
cess to rest fragments or when remaining stone burden
seems larger to still be removed at the same session. Bad
visibility was mainly due to macrohematuria as well as
stone dust leading to turbidity of fluid media and ob-
scuring vision.
Ureteric stent was placed based on following criteria;
prolonged procedures (>60 minutes), large amount of
stone debris or evident ureteral edema/trauma and
prior insertion of an access sheath. Complications were
classified according to the modified Clavien grading sys-
tem [6].
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The Mann–Whitney test was used for comparison of
the univariate variables between the two groups. Out-
come, complications and operative data were compared
using the chi-square and Fisher exact test. Significance
was considered as P-value <0.05. All data are expressed
as calculated mean ± standard error (SEM). Analysis
was done using the computer software SPSS 17.0 for
Windows XP.
Results
No significant difference in median patient’s age between
the two groups (53.9 vs. 53.3 year) was found. A part of
patient cohorts had undergone previous interventions
for calculus disease (39.2% vs. 40% for group I vs. II, re-
spectively). Patients with proximal ureteral stones had
larger calculi (median diameter = 10.70 mm) vs. those
with distal ones (median 8.24 mm) and were more likely
to have DJ-stent at presentation (37.3% vs. 16.2%, respect-
ively). Multiple stones were found in three patients of 1st
group versus five patients in 2nd group (Table 1).
Mean operative time was 81.3 ± 4.5 minutes (25–
140 minutes) in the first group and 65.7 ± 3.8 minutes
(25–120 minutes) in the 2nd group.
Operative characteristics are shown in Table 2. Complete
fragmentation during single procedure was achieved
in all patients of the 1st group (100%). In the 2nd
group, only 42 patients (82.4%) were rendered stone
free by a single laser lithotripsy procedure. A staged
procedure was necessary in 9 patients due to large re-
sidual stone burden and constricted visibility. After a
second laser lithotripsy procedure, 48 (94.1%) patients
were rendered stone free. Third procedure was neces-
sary in one patient. Three patients (5.8%) underwent
SWL as they wished this trial before a third session
and it was successful. Ureteral stents were placed at
the end of 81 (86.2%) procedures to prevent transient
obstruction.Table 1 Patients’ and stones’ characteristics: proximal versus
ureteroscopic Ho:YAG laser lithotripsy
Patients’ characteristics




Stone diameter (mm)* 10.7
Stone burden (mm2) 110
Number of patients with multiple stone burden (%) 3 (5
Number of patients with prior treatments (%) 20 (
Number of patients with preoperative double-J stents (%) 19 (
*mean +/− SD.The overall stone free rate for both groups was 95.8%.
The mean number of all laser procedures was 1.07 ±
0.003, in the proximal ureter 1.1 ± 0.1 and in the distal
ureter 1.0 ± 0.0 (P = 0.027). More successful initial treat-
ments were done in the distal ureteral versus proximal
calculi (100% vs. 82.40%, respectively).
There were no statistical significant differences in pa-
tients’ demographics and operative characteristics when
procedures done for proximal ureteral stones were com-
pared as regards stones’ sizes (≤10 mm vs. ≥10 mm in
diameter) (Table 3). There was no statistical significant
difference between stone free rates after the first versus
second laser lithotripsy in 2nd group for stones smaller
versus larger than 10 mm (94.1% vs. 100%, respectively,
P =0.139) (Table 4).
Overall complication rate was 7.9%. Perioperative com-
plications were recorded in three and four patients in the
1st versus 2nd group, respectively (Table 2). There were no
major perioperative complications noted in this series. All
intraoperative complications were classified as clavien
grade IIIa (small mucosal laceration without leakage), while
all early postoperative complications were Grade II (febrile
urinary tract infections). Ureteral mucosal injuries were
seen in patients with impacted stones and were managed
conservatively resolving within six weeks. Cases of urinary
tract infection responded successfully to parenteral antibi-
otics. Overall and grade-adjusted complication rates did
not depend on the stone location. None of these complica-
tions was due to laser energy.
Stone analysis was available from 75 patients and re-
vealed calcium oxalate monohydrate (COM) (78.7%),
combination of calcium oxalate and phosphate (8.0%),
pure calcium phosphate apatite (8%) and >50% uric acid
stones (5.3%). Current study showed no influence of stone
composition on laser efficacy or complication rates.
The Ho:YAG laser was capable to fragment all stone
compositions to acceptable amounts of debris. Mean
laser time per patient was longer in the proximal groupdistal ureteral calculi in 88 patients treated with
ximal stones 51 Distal stones 37 P value
11 23/14
± 1.8 53.3 ± 3.0 0.829
± 0.7 8.2 ± 0.6 0.020
.7 ± 17.6 64.4 ± 11.6 0.010
.9) 5 (13.5) 0.225
39.2) 15 (40) 0.905
37.3) 6 (16.2) 0.032
Table 2 Operative characteristics, outcome and complications of ureteroscopic Ho:YAG laser lithotripsy in 88 patients:
proximal versus distal ureteral calculi
Number of patients Proximal stones 51 Distal stones 37 P value
Ureteroscope number of procedures (%)
Semirigid 12 (21.1) 37 (100) < 0.001
Flexible 2 (3.5)
Combination 43 (75.4)
Operation time (min)* 81,3 + 4,5 65.7 ± 3.8 0.017
Laser time (sec)* 379.8 + 50.8 154.3 ± 38.1 0.009
Total energy (J)* 2528,8 ± 422.6 1148.5 ± 400.7 0.002
Number of patients with postoperative stent (%) 50 (87.7) 31 (83.8) 0.596
No of intra operative complications (%) 1 (1.8) 2 (5.4) 0.334
No of early post-operative complications (%) 1 (1.8) 3 (8.1) 0.141
Overall SFR per patient 48 (94.1) 37 (100) 0.139
SFR after first treatment per patient (%) 42 (82.4) 37 (100) 0.008
SFR after second treatment per patient (%) 48 (94.1) ——————— ———————
No of laser procedures* 1.1 ± 0.1 1.0 ± 0.0 0.027
*mean +/− SD.
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energy was 2480.3 ± 585.8 vs. 2619.3 ± 547.1 J, respect-
ively (P = 0.483).
Discussion
Over the last decade, lasers have been increasingly used
for intracorporial lithotripsy [1]. Ho:YAG laser has be-
come one of the most widely accepted lasers for this
purpose as compared to ultrasonic, pneumatic and other
laser devices (e.g. pulsed dye laser, Alexandrite laser and
the frequency-double-doubled double-pulse neodymium:
yttrium aluminium garnet (FREDDY) laser) [7].
Technical advancements in instruments (semi-rigid
ureteroscopy), the advances of the new generation flexible
ureteroscopes with greater angles of maximum active
tip deflection and improved durability in addition to theTable 3 Patients and Stones Demographics for 51 patients wi
YAG laser lithotripsy classified as small (<10 mm) and large (





Age (years) 53.1 ± 2.2
Mean stone diameter (mm)* 7.4 ± 0.3
Mean stone burden (mm2)* 45.2 ± 3.9
No of patients with multiple stone burden (%) 2 (6.5)
No. of patients with prior treatments (%) 11 (35.5)
No. of patients with preoperative double-J stents (%) 12 (38.7)
*mean +/− SD.introduction of laser lithotripsy with its precise and
powerful thermal decomposition mechanism and its ex-
cellent safety profile with the ability of delivering laser
energy through small, flexible fibers have blazed the trail
for fragmentation of stones throughout the upper urin-
ary tract [2,8-11].
The meta-analysis of the EAU/AUA nephrolithiasis
guideline panel demonstrated that URS yields significantly
greater stone-free rates for the majority of stone stratifica-
tions [3]. There were a change in trend in the nephro-
lithiasis guidelines, which recommended SWL for proximal
ureter stones <10 mm (1997), to deeming the ureteroscopic
management as a first choice therapy for those stones to
improve efficacy and reduce morbidity. However, both
guidelines still recommend SWL and ureteroscopy as an
option for distal ureteric stones [3,12].th proximal ureteric stones exposed to ureteroscopic Ho:
>10 mm) stones




55.3 ± 3.0 0.549
15.8 ± 1.1 <0.001




Table 4 Operative characteristics of 51 patients with proximal ureteric stones exposed to ureteroscopic Ho:YAG laser
lithotripsy classified as small (<10 mm) and large (>10 mm) stones
Operative characteristics
Proximal ≤ 10 mm (n = 34) Proximal > 10 mm (n = 23) P value
Ureteroscope 0.778
Semirgid 7 (20.6) 5 (21.7)
Flexible 2 (5.9) -
Combination 25 (73.5) 18 (78.3)
Mean OR time (min.) 80.7 ± 6.5 82.3 ± 5.9 0.866
Mean laser time 349.5 ± 69.9 434.3 ± 66.9 0.243
Mean total energy (J) 2480.3 ± 585.8 2619.3 ± 547.1 0.483
Postoperative stent (n) 31 (91.2) 19 (82.6) 0.345
Intra operative complications (n) 1 (2.9) 0 (0) 0.431
Post operative complications (n) 1 (2.9) 0 (0) 0.431
Overall SFR per patient 28/31 (90.3) 20/20 (100) 0.163
SFR after first treatment per patient 25/31 (80.6) 17/20 (85) 0.704
SFR after second treatment per patient 28/31 (90.3) 20/20 (100) 0.163
Laser rate 1,1 ± 0,1 1,2 ± 0,1 0.675
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ureteral calculi requiring lithotripsy for stone retrieval.
We showed a stone-free rate for calculi in the proximal
ureter after one and two procedures of 82.4% and 94.1%,
respectively. This confirms previous reports in literature
about safety and efficacy of ureteroscopic Ho:YAG laser
treatment in treating proximal and distal ureteric stones
[13-15]. In their meta-analysis, Tiselius et al. reported
that re-treatment rates for ureteral stones using URS are
lower than SWL (2.2% vs. 12.1%, respectively). This ad-
vantage was counter-balanced by the higher need for
anesthesia (94.3% vs. 28.3%, respectively) [16].
The current stone-free rate of Ho:YAG laser lithotripsy
in the proximal ureter was not significantly different when
comparing stones with different sizes (≤10 mm vs. ≥10 mm
in diameter or multiple stones) postulating that primary
stone size does not influence the efficacy of the procedure.
This is comparable to previous reports showing stone free
rates of 78% to 96.5% after the first procedure and 88% to
100% after the second laser lithotripsy [3,13-15]. The high
success rate for distal ureter stones in the current series
after a single procedure is consistent with the literature
that shows stone-free rates of 97-100% [10,13,15].
The current mean operative time (81.3 vs. 65.7 mi-
nutes, P = 0.017) and laser time (379.8 vs. 154.3 seconds,
P = 0.009) was shorter for distal ureteral calculi than for
proximal calculi. This could be explained with the larger
stone burdens and our effort to completely “melt down”
the calculi with laser and the effort to remove as much
stone debris as possible leaving no significant frag-
ments. Furthermore, combination of semirigid and flexibleureteroscopy in 75.4% of patients with proximal calculi
may add another explanation.
A second procedure was indicated in some of our
cases. Many causes attribute to the retrograde stone
fragment migration occurring during the treatment of
proximal ureteral stones. Gravitational forces, pressur-
ized irrigation, stone retropulsion during lithotripsy, fail-
ure to access the calculi or large stone burden may bring
the stone out of reach for the semi-rigid ureteroscope
[10,13,17,18]. The use of the flexible ureteroscopes in
combination with access sheaths provides consistent, reli-
able and unimpaired access to the upper urinary tract
facilitating the treatment of complex proximal calculi and
migrated stone fragments and ensuring the clearance of
all stone fragments not deemed to pass spontaneously in
the same ureteroscopic session [11,19,20]. Clear vision to
ease direct access to the targeted stones is essential during
ureteroscopic laser lithotripsy. Decreased visibility leads to
prolonged operative time and increase the potential risk of
injuring the ureter or the flexible ureteroscope.
Generally, routine postoperative ureteral stenting after
ureteroscopic laser lithotripsy is still a subject of debate.
On one hand, stent-related morbidities like bladder irri-
tation and mild back discomfort during urination were
demonstrated to constrain postoperative quality of life.
On the other hand, ureteral stenting was thought to pre-
vent postoperative urinary sepsis by avoiding sudden ur-
eteral obstruction by calculus fragments, blood clots or
ureteral mucosal edema. The clear indications for stenting
include ureteral injury/stricture, solitary kidney, renal in-
sufficiency or large residual stone burden [3]. Furthermore,
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a non-stented versus stented ureteroscopic lithotripsy
reported the same result [21-23]. Ureteral stenting after
uncomplicated ureteric procedures is not a routine at
our institution. However, a transient ureteral stent is placed
in all patients who had ureteral dilatation through the
insertion of access sheath, presented with large and/or
impacted calculi irrespective of the location. This ex-
plains the current high postoperative stenting rates
(87.7% vs. 83.8%, respectively).
URS and laser lithotripsy have proved safety even
where SWL is likely to fail or contraindicated. Major
complications are not common during the procedure
[3,24]. Minor intra or postoperative complications were
reported in a range from 0 to 13% and consist primarily
of pain or urinary tract infection. Ho:YAG laser related
complications are as low as 1% [8,10,13,24]. There were
no major complications observed in the current series.
Further, there was no significant difference of intra and
postoperative complications between both groups. Both
cases of ureteral mucosal injuries occurred in patients
with impacted distal ureteric stones and were success-
fully managed conservatively within six weeks.
Lastly, any laser is as safe or hazardous as the user and
his knowledge and skill, defines how well laser safety
measures managed. The appointment of a laser safety
officer is mandatory for the safety use of lasers [25-27].
His duties include; review of several protective measures,
designation of the appropriate control behaviors accord-
ing to his facility, approving and maintaining all protect-
ive equipment, ensuring that all the staff is properly
educated and trained as well as investigating all accidents
and incidents. He is recommended to all operations of
laser class 3B and 4 in most international regulations [25].
Safety behaviors include e.g. clear communications be-
tween personnel in the operating room and isolated field
with closed doors, which should be marked with attention
light signals. Safety equipment like goggles and fiber fix-
ation tools and laser safety/emergency button should be
available [28]. Personnel and surgeons should treat oper-
ation equipment and catheters with caution to avoid any
parallel damages [28].
The wave length of the Ho:YAG laser varies from
2050 nm to 2100 nm depending on the apparatus. Pulse
duration (150-800 μs) depends on the pulse energy, and
could be selected only in the latest laser systems. Ho:
YAG laser light is mainly absorbed by tissue water, so
that it has a mean optical penetration depth of 0,2 mm.
The mechanism of its laser induced effect for lithotripsy
includes the “Moses” effect, (bubble formation in front
of stones) and thermal vaporization of the stone water,
thus during expansion fragmentation occurs. This mech-
anism is accompanied with small fragments and many
pulses had to be applied, compared to short pulsedlasers (e.g. Q-switch) which produce large fragments in
response to fewer pulses. The later laser lithotripsy is
attributed to the shock wave effect of the laser resulting
from cavitation-collapse mechanisms [29]. Thus with
using Ho:YAG laser pulses, the repulsion effect is reduced
compared to the short-pulse laser lithotripsy [29].
There are some limitations of the current study. First,
its retrospective character has its inherited limitations.
Others include small patients’ series, single institution
and the lack of randomization. Larger randomized series
may be necessary to confirm the long-term efficacy of
this procedure.
Conclusions
Ho:YAG laser lithotripsy during URS appears to be an
adequate tool to disintegrate all kinds of ureteral calculi
with low complication rates. The combination of semirigid
and flexible ureteroscopes ensures direct access to all mi-
grated, repulsed or floated stone fragments. Destruction of
large calculi may be time consuming prolonging operative
time and general anesthesia, and could be an indication
for staged therapy in some cases.
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